Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson’s disease
•Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated mice.•Striatal CBS overexpression rescued MPTP-induced motor deficits and DA neuron losses.•CBS overexpression reduced the MPTP-induced nitrat...
Saved in:
Published in | Brain, behavior, and immunity Vol. 67; pp. 77 - 90 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated mice.•Striatal CBS overexpression rescued MPTP-induced motor deficits and DA neuron losses.•CBS overexpression reduced the MPTP-induced nitrative stress and α-syn nitration.•Glia CBS overexpression offered both direct and indirect protection to DA neurons.
Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson’s disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD. |
---|---|
AbstractList | Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson's disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD.Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson's disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD. •Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated mice.•Striatal CBS overexpression rescued MPTP-induced motor deficits and DA neuron losses.•CBS overexpression reduced the MPTP-induced nitrative stress and α-syn nitration.•Glia CBS overexpression offered both direct and indirect protection to DA neurons. Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson’s disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD. |
Author | Yuan, Xin Bian, Jin-Song Liu, Chun-Feng Wang, Ya-Li Hou, Xiao-Ou Yuan, Yu-Qing Yuan, Bao-Shi Hu, Li-Fang |
Author_xml | – sequence: 1 givenname: Yu-Qing surname: Yuan fullname: Yuan, Yu-Qing organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China – sequence: 2 givenname: Ya-Li surname: Wang fullname: Wang, Ya-Li organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China – sequence: 3 givenname: Bao-Shi surname: Yuan fullname: Yuan, Bao-Shi organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China – sequence: 4 givenname: Xin surname: Yuan fullname: Yuan, Xin organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China – sequence: 5 givenname: Xiao-Ou surname: Hou fullname: Hou, Xiao-Ou organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China – sequence: 6 givenname: Jin-Song surname: Bian fullname: Bian, Jin-Song organization: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore – sequence: 7 givenname: Chun-Feng surname: Liu fullname: Liu, Chun-Feng organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China – sequence: 8 givenname: Li-Fang orcidid: 0000-0001-8326-7779 surname: Hu fullname: Hu, Li-Fang email: hulifang@suda.edu.cn organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China |
BookMark | eNqFkcFu1DAQQC1UpG5LP6A3H7kktR2vE4sTrKCtVMRKbc-W40xWs83ai-0AvfEb_B5fgsty6qFcZqTRvNHMmxNy5IMHQs45qznj6mJb9z3WgvG2Zm3Nl_oVWXCmWSV4o4_IgnWdrkqZH5OTlLaMsWXDuwX5fr3bW4ww0NWH2-pK3NKEG28n9Btqf2CiLvgcsZ8zJJoD_by-W1foh9kVxMMcwwAb8BBtxuApemrpLswJShxgomGkaxsf0Kfgf__8leiACWyCN-T1aKcEZ__yKbn_9PFudVXdfLm8Xr2_qZyUKle9FCAaKUfGFOim66RQ1rUwKjWOYJUVw-i0dFrLvhW8tYJDx8Wy5aqRroPmlLw9zN3H8HWGlM0Ok4Npsh7KmoZroVTHtRaltT20uhhSijAah_nvWTlanAxn5km12Zqi2jypNqw1xWkh-TNyH3Fn4-OLzLsDA-X6bwjRJIfgi9byDZfNEPBFWj-jXXkZOjs9wON_2D9qu615 |
CitedBy_id | crossref_primary_10_1016_j_neuro_2024_06_006 crossref_primary_10_1371_journal_pone_0264891 crossref_primary_10_18632_aging_102394 crossref_primary_10_1021_acschemneuro_8b00288 crossref_primary_10_1096_fj_202002696RR crossref_primary_10_3390_antiox12030652 crossref_primary_10_1042_BSR20221006 crossref_primary_10_18632_aging_103443 crossref_primary_10_1016_j_niox_2020_07_002 crossref_primary_10_1089_ars_2022_0174 crossref_primary_10_1016_j_niox_2019_05_008 crossref_primary_10_1016_j_ejphar_2023_175595 crossref_primary_10_3389_fncel_2019_00366 crossref_primary_10_1016_j_phrs_2024_107507 crossref_primary_10_1038_s41531_024_00798_9 crossref_primary_10_1089_ars_2023_0261 crossref_primary_10_1007_s12640_019_00151_6 crossref_primary_10_1016_j_actbio_2022_11_021 crossref_primary_10_1152_ajpheart_00004_2019 crossref_primary_10_1016_j_neuint_2019_04_011 crossref_primary_10_3390_ijms21103624 crossref_primary_10_1016_j_arr_2021_101262 crossref_primary_10_3390_ijms232012289 crossref_primary_10_3390_biomedicines9020225 crossref_primary_10_3390_biom10070995 crossref_primary_10_1016_j_mehy_2019_109356 crossref_primary_10_1038_s41531_022_00370_3 crossref_primary_10_1080_15384101_2020_1804179 crossref_primary_10_1016_j_ejphar_2023_175966 crossref_primary_10_1186_s12974_024_03268_4 crossref_primary_10_1016_j_neuint_2021_105000 crossref_primary_10_1016_j_neuint_2021_105187 crossref_primary_10_2174_1570159X20666220302101854 crossref_primary_10_1016_j_bbrc_2024_150500 crossref_primary_10_1016_j_phrs_2020_105119 crossref_primary_10_1515_revneuro_2023_0039 crossref_primary_10_1152_ajpendo_00251_2018 crossref_primary_10_12677_IJPN_2022_113006 crossref_primary_10_1016_j_arr_2022_101579 crossref_primary_10_1016_j_tips_2018_03_009 crossref_primary_10_3389_fchem_2017_00072 crossref_primary_10_1039_D5CB00006H crossref_primary_10_1111_acel_13522 crossref_primary_10_1016_j_mcn_2018_10_002 crossref_primary_10_4103_1673_5374_301026 |
Cites_doi | 10.1089/ars.2010.3517 10.1099/jmm.0.46118-0 10.1371/journal.pgen.1006098 10.1038/70978 10.1046/j.1471-4159.1995.64020936.x 10.1126/scisignal.2000464 10.1016/j.expneurol.2007.05.010 10.1016/j.nbd.2005.08.002 10.1016/j.ymeth.2013.05.020 10.1096/fj.05-3724fje 10.1007/s12264-016-0089-7 10.1089/ars.2011.4507 10.1038/ncomms2623 10.1002/mds.26069 10.1111/j.1471-4159.2004.02937.x 10.1093/cvr/cvq248 10.1007/s12272-016-0802-0 10.1016/j.bbrc.2014.07.107 10.1083/jcb.201003122 10.1155/2013/964034 10.1212/WNL.38.8.1285 10.1007/BF00316435 10.1111/j.1471-4159.2006.04283.x 10.1523/JNEUROSCI.16-03-01066.1996 10.1161/CIRCULATIONAHA.107.753467 10.1016/S0002-9440(10)64781-5 10.1111/j.1474-9726.2009.00543.x 10.1089/ars.2010.3671 |
ContentType | Journal Article |
Copyright | 2017 Elsevier Inc. Copyright © 2017 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier Inc. – notice: Copyright © 2017 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1016/j.bbi.2017.07.159 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1090-2139 |
EndPage | 90 |
ExternalDocumentID | 10_1016_j_bbi_2017_07_159 S0889159117303884 |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM 9JO AAAJQ AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABOYX ABWVN ABXDB ACDAQ ACGFO ACGFS ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HMQ HVGLF HZ~ IHE J1W KOM L7B LG5 LUGTX LZ5 M2U M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SIN SNS SPCBC SSB SSN SSY SSZ T5K TN5 UAP UNMZH UPT WUQ XPP XSW Z5R ZGI ZMT ~G- ~S- AACTN AADPK AAIAV ABYKQ AFKWA AFYLN AJBFU AJOXV AMFUW EFLBG RIG SSI AAYXX AFCTW AGRNS BNPGV CITATION SSH 7X8 |
ID | FETCH-LOGICAL-c446t-b42e2344f006e9388426ac7ef66ffea6a2dfc94c994b7217a21e812571634c8e3 |
IEDL.DBID | .~1 |
ISSN | 0889-1591 1090-2139 |
IngestDate | Fri Jul 11 08:39:50 EDT 2025 Thu Apr 24 23:00:53 EDT 2025 Tue Jul 01 04:10:21 EDT 2025 Fri Feb 23 02:27:22 EST 2024 Tue Aug 26 16:32:22 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Hydrogen sulfide Neuroinflammation α-Synuclein nitration Cystathionine β-synthase Parkinson’s disease Nitrative stress |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c446t-b42e2344f006e9388426ac7ef66ffea6a2dfc94c994b7217a21e812571634c8e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8326-7779 |
PQID | 1926681992 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_1926681992 crossref_citationtrail_10_1016_j_bbi_2017_07_159 crossref_primary_10_1016_j_bbi_2017_07_159 elsevier_sciencedirect_doi_10_1016_j_bbi_2017_07_159 elsevier_clinicalkey_doi_10_1016_j_bbi_2017_07_159 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2018 2018-01-00 20180101 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: January 2018 |
PublicationDecade | 2010 |
PublicationTitle | Brain, behavior, and immunity |
PublicationYear | 2018 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Kim, Lee, Lee, Park, Lee, Lee, Lee, Lee (b0055) 2016; 39 Mustafa, Gadalla, Sen, Kim, Mu, Gazi, Barrow, Yang, Wang, Snyder (b0095) 2009; 2 Yao, Ding, Zhou, Wang, Hu, Sun, Hu (b0135) 2005; 92 Kida, Yamada, Tokuda, Marutani, Kakinohana, Kaneki, Ichinose (b0050) 2011; 15 Hu, Lu, Tiong, Dawe, Hu, Bian (b0040) 2010; 9 McGeer, Itagaki, Boyes, McGeer (b0090) 1988; 38 Du, Jin, Hong, Li, Wang, Xu, Wang, Zhang, Jia, Liu, Hu (b0015) 2014; 451 Li, Wang, Wang, Hu, Liu (b0065) 2017; 33 Hu, Lu, Hon Wong, Bian (b0045) 2011; 15 Gerhard, Pavese, Hotton, Turkheimer, Es, Hammers, Eggert, Oertel, Banati, Brooks (b0030) 2006; 21 Washio, Sato, Koseki, Takahashi (b0125) 2005; 54 Schulz, Matthews, Muqit, Browne, Beal (b0105) 1995; 64 Siow, Chen, Wan, Chow, Chang (b0110) 2013; 2013 Vandiver, Paul, Xu, Karuppagounder, Rao, Snowman, Ko, Lee, Dawson, Dawson, Sen, Snyder (b0115) 2013; 4 Kleinknecht, Popova, Lazaro, Pinho, Valerius, Outeiro, Braus (b0060) 2016; 12 Lu, Zhao, Tang, Su, Fan, Ding, Bian, Hu (b0085) 2012; 17 Yong, Hu, Wang, Huang, Bian (b0140) 2010; 88 Winslow, Chen, Corrochano, Acevedo-Arozena, Gordon, Peden, Lichtenberg, Menzies, Ravikumar, Imarisio, Brown, O'Kane, Rubinsztein (b0130) 2010; 190 Liberatore, Jackson-Lewis, Vukosavic, Mandir, Vila, McAuliffe, Dawson, Dawson, Przedborski (b0075) 1999; 5 Anderson, Noorian, Taylor, Anitha, Bernhard, Srinivasan, Greene (b0010) 2007; 207 Duda, Giasson, Chen, Gur, Hurtig, Stern, Gollomp, Ischiropoulos, Lee, Trojanowski (b0020) 2000; 157 Abe, Kimura (b0005) 1996; 16 Hu, Wong, Moore, Bian (b0035) 2007; 100 Warenycia, Smith, Blashko, Kombian, Reiffenstein (b0120) 1989; 63 Li, Whiteman, Guan, Neo, Cheng, Lee, Zhao, Baskar, Tan, Moore (b0070) 2008; 117 Enokido, Suzuki, Iwasawa, Namekata, Okazawa, Kimura (b0025) 2005; 19 Lu, Kavalier, Lukyanov, Gross (b0080) 2013; 62 Scheperjans, Aho, Pereira, Koskinen, Paulin, Pekkonen, Haapaniemi, Kaakkola, Eerola-Rautio, Pohja, Kinnunen, Murros, Auvinen (b0100) 2015; 30 Kleinknecht (10.1016/j.bbi.2017.07.159_b0060) 2016; 12 Duda (10.1016/j.bbi.2017.07.159_b0020) 2000; 157 Warenycia (10.1016/j.bbi.2017.07.159_b0120) 1989; 63 Hu (10.1016/j.bbi.2017.07.159_b0040) 2010; 9 Lu (10.1016/j.bbi.2017.07.159_b0085) 2012; 17 Vandiver (10.1016/j.bbi.2017.07.159_b0115) 2013; 4 Enokido (10.1016/j.bbi.2017.07.159_b0025) 2005; 19 Washio (10.1016/j.bbi.2017.07.159_b0125) 2005; 54 Schulz (10.1016/j.bbi.2017.07.159_b0105) 1995; 64 Yong (10.1016/j.bbi.2017.07.159_b0140) 2010; 88 Scheperjans (10.1016/j.bbi.2017.07.159_b0100) 2015; 30 Mustafa (10.1016/j.bbi.2017.07.159_b0095) 2009; 2 McGeer (10.1016/j.bbi.2017.07.159_b0090) 1988; 38 Yao (10.1016/j.bbi.2017.07.159_b0135) 2005; 92 Kida (10.1016/j.bbi.2017.07.159_b0050) 2011; 15 Liberatore (10.1016/j.bbi.2017.07.159_b0075) 1999; 5 Du (10.1016/j.bbi.2017.07.159_b0015) 2014; 451 Hu (10.1016/j.bbi.2017.07.159_b0035) 2007; 100 Li (10.1016/j.bbi.2017.07.159_b0065) 2017; 33 Kim (10.1016/j.bbi.2017.07.159_b0055) 2016; 39 Abe (10.1016/j.bbi.2017.07.159_b0005) 1996; 16 Li (10.1016/j.bbi.2017.07.159_b0070) 2008; 117 Anderson (10.1016/j.bbi.2017.07.159_b0010) 2007; 207 Gerhard (10.1016/j.bbi.2017.07.159_b0030) 2006; 21 Winslow (10.1016/j.bbi.2017.07.159_b0130) 2010; 190 Hu (10.1016/j.bbi.2017.07.159_b0045) 2011; 15 Lu (10.1016/j.bbi.2017.07.159_b0080) 2013; 62 Siow (10.1016/j.bbi.2017.07.159_b0110) 2013; 2013 |
References_xml | – volume: 207 start-page: 4 year: 2007 end-page: 12 ident: b0010 article-title: Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease publication-title: Exp. Neurol. – volume: 19 start-page: 1854 year: 2005 end-page: 1856 ident: b0025 article-title: Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS publication-title: FASEB J. – volume: 38 start-page: 1285 year: 1988 end-page: 1291 ident: b0090 article-title: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains publication-title: Neurology – volume: 64 start-page: 936 year: 1995 end-page: 939 ident: b0105 article-title: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice publication-title: J. Neurochem. – volume: 2013 start-page: 964034 year: 2013 ident: b0110 article-title: In vivo evidence of increased nNOS activity in acute MPTP neurotoxicity: a functional pharmacological MRI study publication-title: BioMed Res. Int. – volume: 33 start-page: 62 year: 2017 end-page: 72 ident: b0065 article-title: A new perspective for Parkinson's disease: circadian rhythm publication-title: Neurosci. Bull. – volume: 157 start-page: 1439 year: 2000 end-page: 1445 ident: b0020 article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies publication-title: Am. J. Pathol. – volume: 190 start-page: 1023 year: 2010 end-page: 1037 ident: b0130 article-title: alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease publication-title: J. Cell. Biol. – volume: 5 start-page: 1403 year: 1999 end-page: 1409 ident: b0075 article-title: Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease publication-title: Nat. Med. – volume: 12 start-page: e1006098 year: 2016 ident: b0060 article-title: C-Terminal tyrosine residue modifications modulate the protective phosphorylation of serine 129 of alpha-synuclein in a yeast model of Parkinson's disease publication-title: PLoS Genet. – volume: 4 start-page: 1626 year: 2013 ident: b0115 article-title: Sulfhydration mediates neuroprotective actions of parkin publication-title: Nat. Commun. – volume: 54 start-page: 889 year: 2005 end-page: 895 ident: b0125 article-title: Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour publication-title: J. Med. Microbiol. – volume: 100 start-page: 1121 year: 2007 end-page: 1128 ident: b0035 article-title: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia publication-title: J. Neurochem. – volume: 92 start-page: 948 year: 2005 end-page: 961 ident: b0135 article-title: Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes publication-title: J. Neurochem. – volume: 15 start-page: 343 year: 2011 end-page: 352 ident: b0050 article-title: Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease publication-title: Antioxid. Redox Signal. – volume: 21 start-page: 404 year: 2006 end-page: 412 ident: b0030 article-title: In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease publication-title: Neurobiol. Dis. – volume: 39 start-page: 1160 year: 2016 end-page: 1170 ident: b0055 article-title: Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease publication-title: Arch. Pharm. Res. – volume: 30 start-page: 350 year: 2015 end-page: 358 ident: b0100 article-title: Gut microbiota are related to Parkinson's disease and clinical phenotype publication-title: Movement Disord. – volume: 451 start-page: 239 year: 2014 end-page: 245 ident: b0015 article-title: Downregulation of cystathionine beta-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type publication-title: Biochem. Biophys. Res. Commun. – volume: 17 start-page: 849 year: 2012 end-page: 859 ident: b0085 article-title: The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels publication-title: Antioxid. Redox Signal. – volume: 9 start-page: 135 year: 2010 end-page: 146 ident: b0040 article-title: Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models publication-title: Aging Cell – volume: 15 start-page: 405 year: 2011 end-page: 419 ident: b0045 article-title: Hydrogen sulfide: neurophysiology and neuropathology publication-title: Antioxid. Redox Signal. – volume: 62 start-page: 177 year: 2013 end-page: 181 ident: b0080 article-title: S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO publication-title: Methods – volume: 117 start-page: 2351 year: 2008 end-page: 2360 ident: b0070 article-title: Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide publication-title: Circulation – volume: 88 start-page: 482 year: 2010 end-page: 491 ident: b0140 article-title: Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl publication-title: Cardiovasc. Res. – volume: 63 start-page: 131 year: 1989 end-page: 136 ident: b0120 article-title: Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels publication-title: Arch. Toxicol. – volume: 16 start-page: 1066 year: 1996 end-page: 1071 ident: b0005 article-title: The possible role of hydrogen sulfide as an endogenous neuromodulator publication-title: J. Neurosci. – volume: 2 start-page: ra72 year: 2009 ident: b0095 article-title: H2S signals through protein S-sulfhydration publication-title: Sci. Signal. – volume: 15 start-page: 405 year: 2011 ident: 10.1016/j.bbi.2017.07.159_b0045 article-title: Hydrogen sulfide: neurophysiology and neuropathology publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2010.3517 – volume: 54 start-page: 889 year: 2005 ident: 10.1016/j.bbi.2017.07.159_b0125 article-title: Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour publication-title: J. Med. Microbiol. doi: 10.1099/jmm.0.46118-0 – volume: 12 start-page: e1006098 year: 2016 ident: 10.1016/j.bbi.2017.07.159_b0060 article-title: C-Terminal tyrosine residue modifications modulate the protective phosphorylation of serine 129 of alpha-synuclein in a yeast model of Parkinson's disease publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1006098 – volume: 5 start-page: 1403 year: 1999 ident: 10.1016/j.bbi.2017.07.159_b0075 article-title: Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease publication-title: Nat. Med. doi: 10.1038/70978 – volume: 64 start-page: 936 year: 1995 ident: 10.1016/j.bbi.2017.07.159_b0105 article-title: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1995.64020936.x – volume: 2 start-page: ra72 year: 2009 ident: 10.1016/j.bbi.2017.07.159_b0095 article-title: H2S signals through protein S-sulfhydration publication-title: Sci. Signal. doi: 10.1126/scisignal.2000464 – volume: 207 start-page: 4 year: 2007 ident: 10.1016/j.bbi.2017.07.159_b0010 article-title: Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2007.05.010 – volume: 21 start-page: 404 year: 2006 ident: 10.1016/j.bbi.2017.07.159_b0030 article-title: In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2005.08.002 – volume: 62 start-page: 177 year: 2013 ident: 10.1016/j.bbi.2017.07.159_b0080 article-title: S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO publication-title: Methods doi: 10.1016/j.ymeth.2013.05.020 – volume: 19 start-page: 1854 year: 2005 ident: 10.1016/j.bbi.2017.07.159_b0025 article-title: Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS publication-title: FASEB J. doi: 10.1096/fj.05-3724fje – volume: 33 start-page: 62 year: 2017 ident: 10.1016/j.bbi.2017.07.159_b0065 article-title: A new perspective for Parkinson's disease: circadian rhythm publication-title: Neurosci. Bull. doi: 10.1007/s12264-016-0089-7 – volume: 17 start-page: 849 year: 2012 ident: 10.1016/j.bbi.2017.07.159_b0085 article-title: The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2011.4507 – volume: 4 start-page: 1626 year: 2013 ident: 10.1016/j.bbi.2017.07.159_b0115 article-title: Sulfhydration mediates neuroprotective actions of parkin publication-title: Nat. Commun. doi: 10.1038/ncomms2623 – volume: 30 start-page: 350 year: 2015 ident: 10.1016/j.bbi.2017.07.159_b0100 article-title: Gut microbiota are related to Parkinson's disease and clinical phenotype publication-title: Movement Disord. doi: 10.1002/mds.26069 – volume: 92 start-page: 948 year: 2005 ident: 10.1016/j.bbi.2017.07.159_b0135 article-title: Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2004.02937.x – volume: 88 start-page: 482 year: 2010 ident: 10.1016/j.bbi.2017.07.159_b0140 article-title: Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvq248 – volume: 39 start-page: 1160 year: 2016 ident: 10.1016/j.bbi.2017.07.159_b0055 article-title: Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-016-0802-0 – volume: 451 start-page: 239 year: 2014 ident: 10.1016/j.bbi.2017.07.159_b0015 article-title: Downregulation of cystathionine beta-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2014.07.107 – volume: 190 start-page: 1023 year: 2010 ident: 10.1016/j.bbi.2017.07.159_b0130 article-title: alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease publication-title: J. Cell. Biol. doi: 10.1083/jcb.201003122 – volume: 2013 start-page: 964034 year: 2013 ident: 10.1016/j.bbi.2017.07.159_b0110 article-title: In vivo evidence of increased nNOS activity in acute MPTP neurotoxicity: a functional pharmacological MRI study publication-title: BioMed Res. Int. doi: 10.1155/2013/964034 – volume: 38 start-page: 1285 year: 1988 ident: 10.1016/j.bbi.2017.07.159_b0090 article-title: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains publication-title: Neurology doi: 10.1212/WNL.38.8.1285 – volume: 63 start-page: 131 year: 1989 ident: 10.1016/j.bbi.2017.07.159_b0120 article-title: Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels publication-title: Arch. Toxicol. doi: 10.1007/BF00316435 – volume: 100 start-page: 1121 year: 2007 ident: 10.1016/j.bbi.2017.07.159_b0035 article-title: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2006.04283.x – volume: 16 start-page: 1066 year: 1996 ident: 10.1016/j.bbi.2017.07.159_b0005 article-title: The possible role of hydrogen sulfide as an endogenous neuromodulator publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.16-03-01066.1996 – volume: 117 start-page: 2351 year: 2008 ident: 10.1016/j.bbi.2017.07.159_b0070 article-title: Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.753467 – volume: 157 start-page: 1439 year: 2000 ident: 10.1016/j.bbi.2017.07.159_b0020 article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)64781-5 – volume: 9 start-page: 135 year: 2010 ident: 10.1016/j.bbi.2017.07.159_b0040 article-title: Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models publication-title: Aging Cell doi: 10.1111/j.1474-9726.2009.00543.x – volume: 15 start-page: 343 year: 2011 ident: 10.1016/j.bbi.2017.07.159_b0050 article-title: Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2010.3671 |
SSID | ssj0005318 |
Score | 2.4299402 |
Snippet | •Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated... Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts... |
SourceID | proquest crossref elsevier |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 77 |
SubjectTerms | Cystathionine β-synthase Hydrogen sulfide Neuroinflammation Nitrative stress Parkinson’s disease α-Synuclein nitration |
Title | Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson’s disease |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0889159117303884 https://dx.doi.org/10.1016/j.bbi.2017.07.159 https://www.proquest.com/docview/1926681992 |
Volume | 67 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEF9EofSlWG2pH5URig-F9C7J3m7yeD2U8-Pk6Cn4tuxudkuK5sQ7UV_Ef6P_Xv-SzmwSsUUs9Ckk7IZkZ3a-9jczjH1Ke12TFqmMcmlsxAvcinkhe1GWmdjbTBoReh2OjsXwlB-c9c4W2KDNhSFYZSP7a5kepHXzpNOsZueyLDsTAuigMo5jZNI0y6gmKOeSuPzL_ROYRx3jC2geGt2ebAaMlzElobsk1e-MqVzp87rpLykdVM_eMnvT2IzQrz_rLVtw1Qpb7VfoL1_cwQ4EFGcIj6-wV6PmsHyV3ezjVse_K2DwdRINkwkQWENT_jno23IGAaZO_a7cDOZTGI1PxhG66EjsAkKdy8J9D1WpiXhQVqCBAgUOQvscmHqgnOmQPvbr4ecMmsOed-x0b_dkMIyaPguRRWdwHhmeuCTl3OMOdDktZSK0lc4L4b3TQieFtzm3ec4NOoxSJ7FDu6CHrlbKbebS92yxmlbuAwGlHA4Q3jkfc69xaJGTjeQ12g3G-jXWbVdY2aYIOfXCOFct2uyHQqIoIorqSoVEWWOfH6dc1hU4XhqctGRTbWopCkOF-uGlSfxx0h-8969p2y1fKNyTdNCiK4dkUGg1C5ERsHf9_169wV7jXVaHejbZ4vzq2n1E42dutgJ3b7Gl_uDb0Ziu-4fD49-NfwVf |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJwEvE2ygffBxSIgHpKhN4jjJY6mYUrZWk9pJe7Nsx0ZBI53WIuCNf4N_j7-EO8cZAqEh8dr4otTn-_Tv7hh7mWYjndZpHpW5NhGvURTLOs-iotCxM0WuhZ91OJuL6py_u8guttikr4UhWGXQ_Z1O99o6_DIMuzm8aprhggA6aIzjGA9pWhT8Dtum7lTZgG2PpyfV_BfSo0vzeUAPEfSXmx7mpXVDAK-cWnjG1LH07-bpD0Xtrc_xA7YT3EYYd1_2kG3ZdpftjVsMmT9-hVfggZw-Q77L7s7Cffke-zxFacc_WMPkzSKqkgUQXkNRCTqoL80aPFKdRl7ZNWxWMDtbnkUYpSO_a_CtLmv73jemJv5B04ICyhVY8BN0YOWAyqZ9BdmPb9_XEO57HrHz47fLSRWFUQuRwXhwE2me2CTl3KEQ2pJ2MxHK5NYJ4ZxVQiW1MyU3Zck1xoy5SmKLrkGG0VbKTWHTx2zQrlq7T1gpiwuEs9bF3ClcWpfkJjmFroM27oCN-h2WJvQhp3EYl7IHnH2QyBRJTJGjXCJTDtjrG5KrrgnHbYuTnm2yry5FfSjRRNxGxG-Ifjt-_yJ70Z8LiWJJdy2qtcgGiY6zEAVhew__79XP2b1qOTuVp9P5yRG7j0-KLvPzhA0215_sU_SFNvpZOOs_AUj2Bns |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impaired+CBS-H2S+signaling+axis+contributes+to+MPTP-induced+neurodegeneration+in+a+mouse+model+of+Parkinson%E2%80%99s+disease&rft.jtitle=Brain%2C+behavior%2C+and+immunity&rft.au=Yuan%2C+Yu-Qing&rft.au=Wang%2C+Ya-Li&rft.au=Yuan%2C+Bao-Shi&rft.au=Yuan%2C+Xin&rft.date=2018-01-01&rft.issn=0889-1591&rft.volume=67&rft.spage=77&rft.epage=90&rft_id=info:doi/10.1016%2Fj.bbi.2017.07.159&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbi_2017_07_159 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0889-1591&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0889-1591&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0889-1591&client=summon |